Literature DB >> 25880038

Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment.

Meggy Suarez-Carmona1,2, Morgane Bourcy1, Julien Lesage3, Natacha Leroi1, Laïdya Syne1, Silvia Blacher1, Pascale Hubert2, Charlotte Erpicum2, Jean-Michel Foidart1, Philippe Delvenne2, Philippe Birembaut3, Agnès Noël1, Myriam Polette3, Christine Gilles1.   

Abstract

Epithelial-mesenchymal transition (EMT) programmes provide cancer cells with invasive and survival capacities that might favour metastatic dissemination. Whilst signalling cascades triggering EMT have been extensively studied, the impact of EMT on the crosstalk between tumour cells and the tumour microenvironment remains elusive. We aimed to identify EMT-regulated soluble factors that facilitate the recruitment of host cells in the tumour. Our findings indicate that EMT phenotypes relate to the induction of a panel of secreted mediators, namely IL-8, IL-6, sICAM-1, PAI-1 and GM-CSF, and implicate the EMT-transcription factor Snail as a regulator of this process. We further show that EMT-derived soluble factors are pro-angiogenic in vivo (in the mouse ear sponge assay), ex vivo (in the rat aortic ring assay) and in vitro (in a chemotaxis assay). Additionally, conditioned medium from EMT-positive cells stimulates the recruitment of myeloid cells. In a bank of 40 triple-negative breast cancers, tumours presenting features of EMT were significantly more angiogenic and infiltrated by a higher quantity of myeloid cells compared to tumours with little or no EMT. Taken together, our results show that EMT programmes trigger the expression of soluble mediators in cancer cells that stimulate angiogenesis and recruit myeloid cells in vivo, which might in turn favour cancer spread.
Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  angiogenesis; cancer; epithelial-mesenchymal transition; myeloid cells

Mesh:

Substances:

Year:  2015        PMID: 25880038     DOI: 10.1002/path.4546

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  29 in total

Review 1.  Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.

Authors:  Charli Dominguez; Justin M David; Claudia Palena
Journal:  Semin Cancer Biol       Date:  2017-08-18       Impact factor: 15.707

2.  LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy.

Authors:  Gaeul Park; Beomseok Son; JiHoon Kang; Sungmin Lee; Jaewan Jeon; Joo-Hyung Kim; Gi-Ra Yi; HyeSook Youn; Changjong Moon; Seon Young Nam; BuHyun Youn
Journal:  Mol Ther       Date:  2018-10-26       Impact factor: 11.454

3.  Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer.

Authors:  Charli Dominguez; Kristen K McCampbell; Justin M David; Claudia Palena
Journal:  JCI Insight       Date:  2017-11-02

4.  Cyclin D1b induces changes in the macrophage phenotype resulting in promotion of tumor metastasis.

Authors:  Yuxue Wang; Yi Liu; Lei Xiang; Lintao Han; Xiaowei Yao; Yibing Hu; Fenghua Wu
Journal:  Exp Biol Med (Maywood)       Date:  2021-09-13

Review 5.  GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.

Authors:  Anil Kumar; Adeleh Taghi Khani; Ashly Sanchez Ortiz; Srividya Swaminathan
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

Review 6.  Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion.

Authors:  Riley D Z Mullins; Ananya Pal; Thomas F Barrett; Molly E Heft Neal; Sidharth V Puram
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

Review 7.  Understanding cachexia in the context of metastatic progression.

Authors:  Anup K Biswas; Swarnali Acharyya
Journal:  Nat Rev Cancer       Date:  2020-03-31       Impact factor: 60.716

Review 8.  Cancer-Mediated Muscle Cachexia: Etiology and Clinical Management.

Authors:  Thomas Siff; Parash Parajuli; Mohammed S Razzaque; Azeddine Atfi
Journal:  Trends Endocrinol Metab       Date:  2021-04-19       Impact factor: 10.586

9.  Collaborative analysis of multi-gigapixel imaging data using Cytomine.

Authors:  Raphaël Marée; Loïc Rollus; Benjamin Stévens; Renaud Hoyoux; Gilles Louppe; Rémy Vandaele; Jean-Michel Begon; Philipp Kainz; Pierre Geurts; Louis Wehenkel
Journal:  Bioinformatics       Date:  2016-01-10       Impact factor: 6.937

10.  Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells.

Authors:  JiHoon Kang; Wanyeon Kim; TaeWoo Kwon; HyeSook Youn; Joong Sun Kim; BuHyun Youn
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.